CTOR — CLOVIS ONCOLOGY INC
As of Q2 2026, 7 SEC-registered investment managers reported holding CTOR (CLOVIS ONCOLOGY INC) in their latest 13F filings, with a combined reported value of $2.96M across 4.55M shares. That is +7.6% by share count (+322.11K shares) versus the previous quarter, while reported value moved +13.0%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 3 opened new positions, 1 added to existing stakes, 1 trimmed, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
CTOR is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Farallon Capital Management history | Q3 2022 | 51.91M | $34.59M | 0.22% | Hold |
| D. E. Shaw & Co history | Q3 2022 | 26.05M | $16.99M | 0.02% | Hold |
| Bank of America Corp history | Q2 2026 | 3.84M | $2.49M | 0.00% | Hold |
| Citigroup Inc history | Q3 2022 | 2.41M | $1.69M | 0.00% | Hold |
| Vanguard Group history | Q4 2025 | 597.00K | $597.00K | 0.00% | Add |
| JPMorgan Chase & Co history | Q3 2022 | 605.00K | $433.00K | 0.00% | Hold |
| UBS Group AG history | Q2 2026 | 334.62K | $217.50K | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 245.41K | $159.54K | 0.00% | Reduce |
| Renaissance Technologies history | Q3 2025 | 55.90K | $113.48K | 0.00% | New |
| Citadel Advisors history | Q2 2026 | 90.59K | $58.89K | 0.00% | New |
| Northern Trust Corp history | Q2 2026 | 45.75K | $29.74K | 0.00% | Hold |
| BlackRock Inc history | Q1 2026 | 47.45K | $29.42K | 0.00% | Add |
| Two Sigma Investments history | Q4 2025 | 23.52K | $23.52K | 0.00% | New |
| Wells Fargo & Co history | Q2 2026 | 500 | $325 | 0.00% | New |
| Morgan Stanley history | Q2 2026 | 23 | $15 | 0.00% | New |
New Positions (Q2 2026)
- Citadel Advisors 90.59K sh · $58.89K
- Wells Fargo & Co 500 sh · $325
- Morgan Stanley 23 sh · $15
Fully Exited (vs previous quarter)
- BlackRock Inc sold 47.45K sh · $29.42K
Fund Position History — shares by quarter (top 15 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bank of America Corp | — | — | — | — | — | 160 | 160 | 160 | 8.57K | 264 | 214 | 3.84M | 3.84M |
| UBS Group AG | — | — | — | — | — | 1.63K | 24.80K | 49.74K | 15.42K | 55 | 21.46K | 36.84K | 334.62K |
| Geode Capital Management | — | — | — | — | — | — | 12.65K | 20.54K | 57.30K | 167.17K | 220.05K | 264.73K | 245.41K |
| Citadel Advisors | — | — | — | — | — | — | 22.70K | — | — | 17.66K | — | — | 90.59K |
| Northern Trust Corp | — | — | — | — | — | — | — | — | — | 21.76K | 45.75K | 45.75K | 45.75K |
| Wells Fargo & Co | 2.02M | 2.02M | 2.02M | 2.02M | 2.02M | — | — | — | — | — | — | — | 500 |
| Morgan Stanley | 1.01M | 1.03M | 1.03M | 1.03M | 1.03M | — | — | — | — | 5 | — | — | 23 |
| BlackRock Inc | — | — | — | — | — | — | — | — | — | — | 22.34K | 47.45K | — |
| Renaissance Technologies | — | — | — | — | — | — | 11.20K | — | — | 55.90K | — | — | — |
| Two Sigma Investments | — | — | — | — | — | — | — | — | — | — | 23.52K | — | — |
| Vanguard Group | — | — | — | — | — | — | — | — | — | 180.17K | 597.00K | — | — |
| JPMorgan Chase & Co | 605.00K | 605.00K | 605.00K | 605.00K | 605.00K | — | — | — | — | — | — | — | — |
| Citigroup Inc | 6.96M | 3.01M | 3.01M | 2.41M | 2.41M | — | — | — | — | — | — | — | — |
| D. E. Shaw & Co | 25.05M | 26.05M | 26.05M | 26.05M | 26.05M | — | — | — | — | — | — | — | — |
| Farallon Capital Management | 51.91M | 51.91M | 51.91M | 51.91M | 51.91M | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details